Sākums › Multiplā mieloma › Ohajo › Columbus
Multiplā mieloma klīniskie pētījumi Columbus, OH
24 pētījumi par Multiplā mieloma meklē dalībniekus vietās Columbus apkaimē (aptuveni 30 jūdžu rādiusā). Atveriet pētījumu, lai redzētu, kas var piedalīties un kā sazināties ar pētījuma komandu.
Oficiālais pētījuma teksts (angļu valodā)
Meklējat dalībniekus pētījumam? Izceliet to šīs lapas augšdaļā — $99 par 30 dienām →
A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
Notiek dalībnieku piesaiste3. fāze
- Study Site 104, Columbus
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Notiek dalībnieku piesaiste1/2. fāze
- The James Cancer Hospital and Solove Research Institute At Ohio State University, Columbus
Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
Notiek dalībnieku piesaiste2. fāze
- Ohio State University Medical Center Dept. of Internal Medicine, Division of Hematology, Columbus
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
Notiek dalībnieku piesaiste3. fāze
- Ohio State University, Columbus
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Notiek dalībnieku piesaiste3. fāze
- The Ohio State University- James Cancer Hospital, Columbus
- OhioHealth, Columbus
Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
Notiek dalībnieku piesaiste1. fāze
- Ohio State University Comprehensive Cancer Center, Columbus
Collection of Tissue Samples for Cancer Research
Notiek dalībnieku piesaisteNovērojumu pētījums
- Ohio State University, Columbus
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Notiek dalībnieku piesaiste2. fāze
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Notiek dalībnieku piesaiste3. fāze
- Columbus Oncology and Hematology Associates Inc, Columbus
- Riverside Methodist Hospital, Columbus
- Grant Medical Center, Columbus
- un vēl 7
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
Notiek dalībnieku piesaiste1/2. fāze
- Ohio State University, Columbus
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Notiek dalībnieku piesaiste3. fāze
- Research Site, Columbus
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
Notiek dalībnieku piesaiste1. fāze
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Notiek dalībnieku piesaiste1/2. fāze
- The Ohio State University /ID# 271336, Columbus
Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma
Notiek dalībnieku piesaiste2. fāze
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
Notiek dalībnieku piesaiste1. fāze
- The Ohio State University James Cancer Hospital, Columbus
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Notiek dalībnieku piesaiste3. fāze
- Ohio State Medical Center, James Cancer Center, Columbus
- Ohio Health Research Institute, Columbus
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
Notiek dalībnieku piesaiste2. fāze
- The Ohio State University- The James Cancer Hospital and Solove Research Institute, Columbus
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
Notiek dalībnieku piesaiste2. fāze
- The Ohio State University Comprehensive Cancer Center, Columbus
A Cognitive Training Intervention for Improving Cognitive and Neurological Outcomes in Patients Undergoing Treatment for Relapsed or Refractory Multiple Myeloma or B-cell Non-Hodgkin Lymphoma
Notiek dalībnieku piesaiste
- Ohio State University Comprehensive Cancer Center, Columbus
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Notiek dalībnieku piesaiste1. fāze
- The Ohio State University, Columbus
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Notiek dalībnieku piesaiste3. fāze
- GSK Investigational Site, Columbus
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
Notiek dalībnieku piesaiste1/2. fāze
- Ohio State University James Cancer Hospital, Columbus
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Notiek dalībnieku piesaiste1/2. fāze
- The Ohio State University Comprehensive Cancer Center, Columbus
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
Notiek dalībnieku piesaisteNovērojumu pētījums
- Ohio State University Medical Center, Columbus
Multiplā mieloma pētījumi citās pilsētās
- New York City, NY60 pētījumi
- Boston, MA42 pētījumi
- Atlanta, GA41 pētījums
- Houston, TX38 pētījumi
- Durham, NC37 pētījumi
- Nashville, TN32 pētījumi
- Denver, CO27 pētījumi
- Rochester, MN24 pētījumi
- St. Louis, MO24 pētījumi
- Baldwin Park, CA23 pētījumi
- Chicago, IL22 pētījumi
- Seattle, WA22 pētījumi
Citi pētījumi Columbus
- Mazšūnu plaušu vēzis56 pētījumi
- Krūts vēzis39 pētījumi
- Olnīcu vēzis39 pētījumi
- Vēzis (visi veidi)38 pētījumi
- Plaušu vēzis37 pētījumi
- Akūta mieloīdā leikēmija35 pētījumi
- Hroniska limfocītiska leikēmija28 pētījumi
- Metastātisks vēzis27 pētījumi
- Endometrija vēzis25 pētījumi
- Kolorektālais vēzis24 pētījumi
- Priekšdziedzera vēzis24 pētījumi
- Melanoma21 pētījums
No ClinicalTrials.gov, dati iegūti 2026. gada 5. okt.. Katram pētījumam ir savi dalības nosacījumi; pētījuma komanda nosaka, kas var piedalīties.